CHOC Walk in the Park 2011 at Disneyland
On Sunday, October 16, 2011, several staff from Baum, Hedlund, Aristei & Goldman and Robinson Calcagnie Robinson Shapiro Davis, Inc. (RCRSD), will be participating in a walk for CHOC Hospital, Children’s Hospital of Orange County, where one of our antidepressant birth defect clients has been cared for over the years. This walk will help raise money for the hospital and contribute to the continued excellent care that this hospital has given to so many children.
Visit Our Choc Walk in the Park Team Page

CHOC Walk Information
Get ready for the happiest Walk on earth! Join us on October 16, 2011 at the 21st annual CHOC Walk in the Park presented by Disneyland® Resort.
Proceeds from this event will support health care programs, education and research at CHOC Childrens.
Click Here to Donate
Mothers who have taken antidepressants during their pregnancy because they thought it was safe have given birth to babies with birth defects ranging from cleft lip to life-threatening congenital heart defects and, in some cases, the babies have been required to get full heart transplants.
Our legal birth defects team consists of 10 attorneys from two prestigious law firms that have more experience handling antidepressant birth defect cases than any other firm in the country. Through our litigation and consultation with medical experts, we are establishing the link between antidepressants and congenital defects.
Karen Barth Menzies, a partner at RCRSD, gained national recognition in the SSRI antidepressant litigation arena while working at Baum Hedlund for more than a decade. She and a team of Baum Hedlund lawyers and staff filed the first SSRI antidepressant injury class action in 2001 which helped bring national attention to the dangers of SSRIs.

The drug product liability lawyers at Baum Hedlund and RCRSD have seen the harm caused by antidepressants and the lives destroyed and therefore, have gone above and beyond the court room to increase awareness of the drugs’ risks. Baum Hedlund lawyers have traveled to Washington, D.C. on numerous occasions, met with members of Congress, the FDA, and Department of Health and Human Services officials. They have assisted Congressional Investigators in their investigations of drug safety issues and FDA failures. Karen Barth Menzies, has testified four times before the government regarding the increased risk of suicidality in children, adolescents and adults of all ages. During her February 2004 testimony before the Food and Drug Administration’s Psychopharmacologic Drugs Advisory Committee, “Put me out of business for the right reasons — warn about these drugs.”
Return to News Menu
|